Treatment of Advanced NSCLC in the Elderly



As part of ESMO's continuous commitment to offering beneficial educational material relevant to your work and practice in order to receive your certificate, please complete the Evaluation Survey, which will take approximately 5 minutes. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Did your undertaking of this E-Learning module allow you to discuss management of elderly patients with advanced NSCLC to maximise clinical outcomes? (1-not at all; 5-a lot)

2. Did this E-Learning module outline the strategy for use of chemotherapy and targeted treatments in elderly patients with advanced NSCLC? (1-not at all; 5-a lot)

3. Did this E-Learning module summarise the safety and efficacy data clarifying the role of different chemotherapy and targeted agents in the care of elderly patients with advanced NSCLC? (1-not at all; 5-a lot)

4. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

5. How would you rate the interactivity level offered in the E-Learning material? (1-poor; 5-excellent)

6. Was the information useful and relevant to your work and practice? (1-not at all; 5-completely)

7. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

8. If you would like to add your personal comments or make suggestions to improve future ESMO E-Learning material, please write in the box below: